Skip to main content

LKFT · Lakefront Biotherapeutics NV · Investor Relations

Track LKFT — free
$32.28 -0.05 (-0.15%) At close · Oct 30 Q1 2026 earnings call transcript
Market Cap
$2.13B
Shares
65.90M
Volume · Oct 30 164.06K Avg daily vol (3M) 283.93K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-11-11 00:00 UTC Third quarter 2026 results Results publication

Past events

Date Event Type
2026-09-15 Morgan Stanley 24th Annual Global Healthcare Conference Conference
2026-08-10 Half Year 2026 results Results publication
2026-08-10 Half year 2026 results Results publication
2026-05-07 Q1 FY2026 Earnings conference call (announced in 6-K) Earnings call
2026-05-06 First quarter 2026 results Results publication
2026-04-28 Annual Shareholders’ Meeting Shareholder meeting
2026-04-28 Annual Shareholders’ meeting Shareholder meeting
2026-03-31 Conference Call Conference
2026-03-02 TD Cowen 46th Annual Health Care Conference Conference
2026-02-24 Earnings conference call (announced in 6-K) Earnings call
2025-11-19 Jefferies 2025 London Healthcare Conference Conference
2025-11-06 Q3 2025 Results Results publication
2025-05-21 RBC Capital Markets Global Healthcare Conference Conference
2025-04-29 Annual Shareholders’ Meeting Shareholder meeting
2025-04-24 Q1 2025 Results Results publication
2025-04-03 Kempen Life Sciences Conference Conference
2025-03-27 Annual Report 2024 Event
2025-03-11 Barclays Global Healthcare Conference Conference
2025-03-03 TD Cowen 45th Annual Healthcare Conference Conference
2025-02-13 FY 2024 Results Results publication
2025-01-13 J.P. Morgan Healthcare Conference Conference
2025-01-08 Galapagos 2025 Business Update Event
2024-12-17 KBC Bolero site visit Event
2024-12-10 Deutsche Bank C-level Call Event
2024-11-19 Jefferies Healthcare Conference Conference

Source: https://lakefrontbio.com/investors/corporate-governance/

Key facts CIK 1421876 CUSIP 36315X101 13F (30d) 14 filings 14 filers Visit website Investor relations